Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus-Report 2: Diabetic Kidney Disease.
diabetic kidney disease
diabetic nephropathy
foveal avascular zone
oculomics
optical coherence tomography angiography
perfusion density
vessel density
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
30 Dec 2021
30 Dec 2021
Historique:
received:
23
11
2021
revised:
21
12
2021
accepted:
24
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
12
1
2022
Statut:
epublish
Résumé
The purpose of this study is to investigate potential associations between optical coherence tomography angiography (OCTA) parameters and diabetic kidney disease (DKD) categories in type 1 diabetes mellitus (T1DM) patients and controls. A complete ocular and systemic examination, including OCTA imaging tests and bloods, was performed. OCTA parameters included vessel density (VD), perfusion density (PD), foveal avascular zone area (FAZa), perimeter (FAZp) and circularity (FAZc) in the superficial vascular plexus, and DKD categories were defined according to glomerular filtration rate (GFR), albumin-creatinine ratio (ACR) and KDIGO prognosis risk classifications. A total of 425 individuals (1 eye/1 patient) were included. Reduced VD and FAZc were associated with greater categories of GFR (
Identifiants
pubmed: 35011940
pii: jcm11010197
doi: 10.3390/jcm11010197
pmc: PMC8745787
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fundación La Marató TV3
ID : 201633.10
Organisme : Instituto de Salud Carlos III
ID : PI18/00518
Références
Sci Rep. 2017 May 31;7(1):2575
pubmed: 28566760
Lancet Digit Health. 2020 Jun;2(6):e295-e302
pubmed: 33328123
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO307-BIO315
pubmed: 29059262
Diabetes Care. 2021 May;44(5):1168-1175
pubmed: 33402366
Ophthalmol Ther. 2020 Mar;9(1):139-148
pubmed: 32077043
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT362-70
pubmed: 27409494
Br J Ophthalmol. 2018 Sep;102(9):1226-1231
pubmed: 29259019
Surv Ophthalmol. 2021 Nov 5;:
pubmed: 34748794
Cells. 2021 Mar 04;10(3):
pubmed: 33806492
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):190-196
pubmed: 28114579
Semin Ophthalmol. 2021 Aug 18;36(5-6):406-412
pubmed: 33689564
Diagnostics (Basel). 2021 Aug 25;11(9):
pubmed: 34573883
Nat Biomed Eng. 2021 Jun;5(6):533-545
pubmed: 34131321
Diabet Med. 2013 Nov;30(11):1333-41
pubmed: 23909911
Prog Retin Eye Res. 2018 May;64:1-55
pubmed: 29229445
PLoS One. 2021 Jul 9;16(7):e0253928
pubmed: 34242286
Transl Vis Sci Technol. 2020 Sep 30;9(10):34
pubmed: 33062397
J Diabetes Complications. 2018 Apr;32(4):393-399
pubmed: 29478814
Ophthalmology. 2003 Sep;110(9):1677-82
pubmed: 13129861
Lancet Glob Health. 2013 Dec;1(6):e339-49
pubmed: 25104599
Curr Vasc Pharmacol. 2020;18(2):117-124
pubmed: 31057114
Br J Ophthalmol. 2020 Dec;104(12):1768-1773
pubmed: 32098859
Ophthalmologica. 2020;243(4):271-279
pubmed: 31775153
Retina. 2015 Nov;35(11):2364-70
pubmed: 26469537
Diabetes Res Clin Pract. 2018 Aug;142:243-253
pubmed: 29879494
Retina. 2015 Nov;35(11):2353-63
pubmed: 26465617
Microcirculation. 2019 Oct;26(7):e12555
pubmed: 31066106
Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2212-2221
pubmed: 29715365
Am J Ophthalmol. 2015 Jul;160(1):35-44.e1
pubmed: 25896459
PLoS One. 2018 Aug 9;13(8):e0202103
pubmed: 30092018
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
J Ophthalmol. 2020 Nov 30;2020:2473949
pubmed: 33763237
JAMA Ophthalmol. 2017 Apr 1;135(4):306-312
pubmed: 28208170
Sci Rep. 2018 Aug 14;8(1):12146
pubmed: 30108264
Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1687-1698
pubmed: 31147842
Retina. 2020 Feb;40(2):333-344
pubmed: 31972804
Acta Diabetol. 2018 May;55(5):469-477
pubmed: 29453673
J Ophthalmic Vis Res. 2018 Oct-Dec;13(4):487-497
pubmed: 30479720
Diabetes Res Clin Pract. 2020 Oct;168:108373
pubmed: 32827591
BMC Med Imaging. 2019 Nov 21;19(1):91
pubmed: 31752726
Int J Retina Vitreous. 2021 Dec 5;7(1):73
pubmed: 34865654